Have a personal or library account? Click to login

Evaluating BCG Therapy in High- and Low-Grade Non-Muscle-Invasive Bladder Cancer: Insights from a Latvian Hospital (2019–2024)

Open Access
|Sep 2025

Authors

Reičela Heinrihsone

reicela.heinrihsone@rsu.lv

Department of Biology and Microbiology, Rīga Stradiņš University, Rīga, Latvia

Maksimilians Rate

Faculty of Medicine and Life Sciences, University of Latvia, Rīga, Latvia

Ērika Bitiņa-Barlote

Institute of Oncology and Molecular Genetics, Rīga Stradiņš University, Rīga, Latvia
Department of Urology, Pauls Stradiņš Clinical University Hospital, Latvia

Juris Plonis

Institute of Oncology and Molecular Genetics, Rīga Stradiņš University, Rīga, Latvia
Department of Urology, Pauls Stradiņš Clinical University Hospital, Latvia

Edvīns Miklaševičs

Department of Biology and Microbiology, Rīga Stradiņš University, Rīga, Latvia

Miki Nakazawa-Miklaševiča

Department of Biology and Microbiology, Rīga Stradiņš University, Rīga, Latvia
Institute of Oncology and Molecular Genetics, Rīga Stradiņš University, Rīga, Latvia
DOI: https://doi.org/10.2478/prolas-2025-0013 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Language: English
Page range: 198 - 204
Submitted on: May 26, 2025
Accepted on: Aug 12, 2025
Published on: Sep 27, 2025
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 times per year

© 2025 Reičela Heinrihsone, Maksimilians Rate, Ērika Bitiņa-Barlote, Juris Plonis, Edvīns Miklaševičs, Miki Nakazawa-Miklaševiča, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution 4.0 License.